Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.38B
Enterprise Value2.06B
P/E Ratio39.13
PEG Ratio4.57
Price/Sales Ratio8.88
Price/Book Ratio2.86
Enterprise/Revenue7.64
Enterprise/EBITDA30.69

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.23
Operating Margin0.28
AD

Management Effectiveness

Return On Assets0.07
Return On Equity0.07

Income Statement

Revenue265.36M
Revenue/Share1.67
Gross Profit102.86M
EBITDA63.09M
Net Income54.21M
Diluted EPS0.34

Balance Sheet

Total Cash732.02M
Total Cash/Share4.58
Total Debt0
Total Debt/Equity0
Current Ratio16.76
Book Value Per Share5.18

Price History

52-Week Change-4.26
52-Week High18.25
52-Week Low11.53
Moving Average 50 Days14.2
Moving Average 200 Days14.86

Statistics

Average Volume5.48M
Shares Outstanding160M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield2.02
Payout Ratio0.77
Last Split Factor2:1
Last Split DateJuly 04, 2017
AD